Tyrosine 547 constitutes an essential part of the catalytic mechanism of dipeptidyl peptidase IV

被引:65
作者
Bjelke, JR
Christensen, J
Branner, S
Wagtmann, N
Olsen, C
Kanstrup, AB
Rasmussen, HB
机构
[1] Novo Nordisk AS, Prot Struct, DK-2880 Bagsvaerd, Denmark
[2] Novo Nordisk AS, Prot Sci, DK-2880 Bagsvaerd, Denmark
[3] Novo Nordisk AS, Canc & Immunobiol, DK-2880 Bagsvaerd, Denmark
[4] Novo Nordisk AS, Med Chem, DK-2880 Bagsvaerd, Denmark
[5] Univ Copenhagen, Panum Inst, Inst Med Biochem & Genet, DK-2200 Copenhagen, Denmark
关键词
D O I
10.1074/jbc.M405400200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human dipeptidyl peptidase IV (DPP- IV) is a ubiquitously expressed type II transmembrane serine protease. It cleaves the penultimate positioned prolyl bonds at the N terminus of physiologically important peptides such as the incretin hormones glucagon-like peptide 1 and glucose-dependent insulinotropic peptide. In this study, we have characterized different active site mutants. The Y547F mutant as well as the catalytic triad mutants S630A, D708A, and H740L showed less than 1% wild type activity. X-ray crystal structure analysis of the Y547F mutant revealed no overall changes compared with wild type apoDPP-IV, except the ablation of the hydroxyl group of Tyr(547) and a water molecule positioned in close proximity to Tyr(547). To elucidate further the reaction mechanism, we determined the crystal structure of DPP- IV in complex with diisopropyl fluorophosphate, mimicking the tetrahedral intermediate. The kinetic and structural findings of the tyrosine residue are discussed in relation to the catalytic mechanism of DPP- IV and to the inhibitory mechanism of the 2-cyanopyrrolidine class of potent DPP- IV inhibitors, proposing an explanation for the specificity of this class of inhibitors for the S9b family among serine proteases.
引用
收藏
页码:34691 / 34697
页数:7
相关论文
共 35 条
[1]  
Abbott C. A., 2002, ECTOPEPTIDASES CD13A, P171
[2]   Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8 [J].
Abbott, CA ;
Yu, DMT ;
Woollatt, E ;
Sutherland, GR ;
McCaughan, GW ;
Gorrell, MD .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (20) :6140-6150
[3]   Two highly conserved glutamic acid residues in the predicted β propeller domain of dipeptidyl peptidase IV are required for its enzyme activity [J].
Abbott, CA ;
McCaughan, GW ;
Gorrell, MD .
FEBS LETTERS, 1999, 458 (03) :278-284
[4]   GENOMIC ORGANIZATION, EXACT LOCALIZATION, AND TISSUE EXPRESSION OF THE HUMAN CD26 (DIPEPTIDYL PEPTIDASE-IV) GENE [J].
ABBOTT, CA ;
BAKER, E ;
SUTHERLAND, GR ;
MCCAUGHAN, GW .
IMMUNOGENETICS, 1994, 40 (05) :331-338
[5]   Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes [J].
Ahrén, B ;
Landin-Olsson, M ;
Jansson, PA ;
Svensson, M ;
Holmes, D ;
Schweizer, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05) :2078-2084
[6]   Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes [J].
Ahrén, B ;
Simonsson, E ;
Larsson, H ;
Landin-Olsson, M ;
Torgeirsson, H ;
Jansson, PA ;
Sandqvist, M ;
Båvenholm, P ;
Efendic, S ;
Eriksson, JW ;
Dickinson, S ;
Holmes, D .
DIABETES CARE, 2002, 25 (05) :869-875
[7]   TRANSITION-STATE STABILIZATION AT THE OXYANION BINDING-SITES OF SERINE AND THIOL PROTEINASES - HYDROLYSES OF THIONO AND OXYGEN ESTERS [J].
ASBOTH, B ;
POLGAR, L .
BIOCHEMISTRY, 1983, 22 (01) :117-122
[8]   STRUCTURE OF THE MOUSE DIPEPTIDYL PEPTIDASE-IV (CD26) GENE [J].
BERNARD, AM ;
MATTEI, MG ;
PIERRES, M ;
MARGUET, D .
BIOCHEMISTRY, 1994, 33 (50) :15204-15214
[9]  
Brandt W, 2000, ADV EXP MED BIOL, V477, P97
[10]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254